PortfoliosLab logoPortfoliosLab logo
ISIN
US25490K3234
CUSIP
25490K323
Issuer
Direxion
Inception Date
May 28, 2015
Region
North America (U.S.)
Leveraged
3x
Index Tracked
S&P Biotechnology Select Industry Index (300%)
Distribution Policy
Distributing
Asset Class
Equity
Asset Class Size
Multi-Cap
Asset Class Style
Growth
Assets Under Management
$568M

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

LABU Performance Chart

Direxion Daily S&P Biotech Bull 3x Shares (LABU) is up 47.6% since the beginning of the year. LABU is currently trading at $235 per share. Investors who bought $1,000 worth of LABU shares 5 years ago would now be looking at an investment worth $156.


Loading charts...

S&P 500 Index

Returns By Period

Direxion Daily S&P Biotech Bull 3x Shares (LABU) has returned 47.57% so far this year and 324.35% over the past 12 months. Over the last ten years, LABU has returned -7.18% per year, falling short of the S&P 500 Index benchmark, which averaged 13.71% annually.


Direxion Daily S&P Biotech Bull 3x Shares

1D
2.26%
1M
34.26%
YTD
47.57%
6M
36.98%
1Y
324.35%
3Y*
23.36%
5Y*
-31.01%
10Y*
-7.18%

Benchmark (S&P 500 Index)

1D
-1.44%
1M
-1.45%
YTD
7.60%
6M
6.59%
1Y
22.24%
3Y*
19.20%
5Y*
11.54%
10Y*
13.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LABU Monthly Returns History

Based on dividend-adjusted daily data since May 28, 2015, LABU's average daily return is +0.10%, while the average monthly return is +1.21%. At this rate, an investment would double in approximately 4.8 years.

Historically, 51% of months were positive and 49% were negative. The best month was Apr 2020 with a return of +63.7%, while the worst month was Jan 2016 at -66.1%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.

On a daily basis, LABU closed higher 52% of trading days. The best single day was Nov 9, 2016 with a return of +33.4%, while the worst single day was Mar 16, 2020 at -33.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20264.06%4.12%-3.83%6.91%9.99%20.44%47.57%
20256.31%-13.96%-25.84%-0.56%-17.05%13.61%7.38%13.48%35.14%40.00%27.17%-3.86%79.17%
2024-8.52%35.81%-12.31%-31.53%13.67%9.97%19.44%4.10%-8.73%-7.12%4.98%-28.30%-26.02%
202318.10%-21.32%-25.27%13.44%12.03%-5.01%2.03%-18.38%-22.68%-28.61%41.91%58.33%-13.41%
2022-45.81%-14.97%-5.55%-48.05%-28.50%15.81%24.18%3.70%-19.24%6.13%0.94%-5.86%-80.36%
202125.63%-12.47%-28.54%-0.22%-20.00%16.90%-25.69%21.14%-16.59%-3.44%-20.43%-15.27%-64.15%

Benchmark Metrics

Direxion Daily S&P Biotech Bull 3x Shares has an annualized alpha of -16.60%, beta of 3.41, and R2 of 0.39 versus S&P 500 Index. Calculated based on daily prices since May 28, 2015.

  • This ETF captured 300.38% of S&P 500 Index gains and 250.70% of its losses - amplifying both gains and losses, but participating more in upside than downside.
  • R2 of 0.39 means the benchmark explains less than half of this ETF's behavior - treat beta with caution or consider switching to a more representative benchmark.

Alpha
-16.60%
Beta
3.41
0.39
Upside Capture
300.38%
Downside Capture
250.70%

Expense Ratio

LABU has a high expense ratio of 1.12%, indicating above-average management fees.


Return for Risk

Risk / Return Rank

LABU ranks 91 for risk / return — in the top 91% of ETFs on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


LABU Risk / Return Rank: 9191
Overall Rank
LABU Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
LABU Sortino Ratio Rank: 8686
Sortino Ratio Rank
LABU Omega Ratio Rank: 7878
Omega Ratio Rank
LABU Calmar Ratio Rank: 9797
Calmar Ratio Rank
LABU Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LABUBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

+2.37

Sortino ratioReturn per unit of downside risk

+1.23

Omega ratioGain probability vs. loss probability

1.44

1.32

+0.12

Calmar ratioReturn relative to maximum drawdown

10.64

2.46

+8.19

Martin ratioReturn relative to average drawdown

29.90

10.92

+18.98

Dividends

Dividend History

Direxion Daily S&P Biotech Bull 3x Shares provided a 0.52% dividend yield over the last twelve months, with an annual payout of $1.23 per share.


0.00%0.20%0.40%0.60%0.80%$0.00$1.00$2.00$3.00$4.00201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM202520242023202220212020201920182017
Dividend$1.23$1.34$0.31$0.42$0.00$0.00$0.00$3.26$4.22$2.65

Dividend yield

0.52%0.84%0.35%0.35%0.00%0.00%0.00%0.28%0.64%0.17%

Monthly Dividends

The table displays the monthly dividend distributions for Direxion Daily S&P Biotech Bull 3x Shares. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.11$0.00$0.00$0.22$0.00$0.00$0.10$0.00$0.00$0.91$1.34
2024$0.00$0.00$0.16$0.00$0.00$0.15$0.00$0.00$0.00$0.00$0.00$0.00$0.31
2023$0.00$0.00$0.00$0.00$0.00$0.17$0.00$0.00$0.04$0.00$0.00$0.21$0.42
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Direxion Daily S&P Biotech Bull 3x Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Direxion Daily S&P Biotech Bull 3x Shares was 99.18%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current Direxion Daily S&P Biotech Bull 3x Shares drawdown is 94.80%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-99.18%Apr 2025
9y 8mo
10y 11moJul 2015 - now
2015 bear market2015
-20.23%Jul 2015
15d6d
21dJun 2015 - Jul 2015
2015 pullback2015
-4.93%Jun 2015
3d5d
8dJun 2015 - Jun 2015
2015 pullback2015
-1.91%Jun 2015
0s1d
1dJun 2015 - Jun 2015
2015 pullback2015
-0.95%Jun 2015
0s1d
1dJun 2015 - Jun 2015

Drawdown Indicators


LABUBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.18%

-56.78%

-42.40%

Max Drawdown (1Y)

Largest decline over 1 year

-30.70%

-9.10%

-21.60%

Max Drawdown (3Y)

Largest decline over 3 years

-78.30%

-18.90%

-59.40%

Max Drawdown (5Y)

Largest decline over 5 years

-97.59%

-25.43%

-72.16%

Max Drawdown (10Y)

Largest decline over 10 years

-98.96%

-33.92%

-65.04%

Current Drawdown

Current decline from peak

-94.80%

-3.21%

-91.59%

Average Drawdown

Average peak-to-trough decline

-81.72%

-10.71%

-71.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.91%

2.04%

+8.87%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Portfolio Analyzer

Build a portfolio with LABU

Add Direxion Daily S&P Biotech Bull 3x Shares to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with LABU